Differential Expression of mTOR Signalling Components in Drug Resistance in Ovarian Cancer

Journal article

Peer reviewed

H Foster, HM Coley, A Goumenou, G Pados, A Harvey and E Karteris

ANTICANCER RESEARCH, Vol.30(9), pp.3529-3534

01/09/2010

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

Ovarian cancer

DEPTOR

mTOR

S6 kinase

paclitaxel resistance

MAMMALIAN TARGET

CELL-LINES

RAPAMYCIN

MECHANISMS

PACLITAXEL

CHEMOTHERAPY

TRANSPORT

AGENTS

COMBINATION

INHIBITION

24 Record Views

Title: Differential Expression of mTOR Signalling Components in Drug Resistance in Ovarian Cancer
Creators: H Foster
HM Coley
A Goumenou
G Pados
A Harvey
E Karteris
Publication Details: ANTICANCER RESEARCH, Vol.30(9), pp.3529-3534
Publisher: INT INST ANTICANCER RESEARCH
Date published: 01/09/2010
Date submitted: 17/05/2017
Identifiers: 99516157102346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article